<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05023629</url>
  </required_header>
  <id_info>
    <org_study_id>v.2.0</org_study_id>
    <nct_id>NCT05023629</nct_id>
  </id_info>
  <brief_title>STunning After Balloon Occlusion</brief_title>
  <acronym>STABO</acronym>
  <official_title>STunning After Balloon Occlusion, A Single-center, Single-arm, Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vastra Gotaland Region</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vastra Gotaland Region</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to examine in-depth cardiac function and morphology after short-term&#xD;
      coronary occlusion by balloon inflation in patients with stable coronary artery disease (CAD)&#xD;
      who undergo percutaneous coronary intervention (PCI).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary objectives:&#xD;
&#xD;
        1. To determine the time-course for the resolution of regional myocardial function after&#xD;
           short-term coronary artery occlusion in patients with stable CAD who undergo PCI.&#xD;
&#xD;
           Secondary objectives:&#xD;
&#xD;
        2. To confirm by cardiac magnetic resonance imaging that no myocardial injury occurs after&#xD;
           short-term coronary occlusion in patients who undergo PCI due to stable CAD.&#xD;
&#xD;
        3. To establish a clinical model for studying myocardial stunning.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 6, 2021</start_date>
  <completion_date type="Anticipated">December 15, 2025</completion_date>
  <primary_completion_date type="Anticipated">July 15, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>A single-center, single-arm, prospective study</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Precent Akinesia</measure>
    <time_frame>30 minutes post balloon occlusion</time_frame>
    <description>Time until recovery of percent akinesia (percent Akinesia; defined as more than 80 percent recovery compared to percent Akinesia at 30 minutes post balloon occlusion).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Difference in percent Akinesia</measure>
    <time_frame>30 minutes</time_frame>
    <description>Difference in percent Akinesia at 30 minutes compared to baseline (before balloon occlusion).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in radial myocardial Strain</measure>
    <time_frame>30 minutes</time_frame>
    <description>Difference in radial myocardial Strain (in percent) in the myocardial segments subtended by the target vessel at 30 minutes compared to baseline measured with speckle tracking.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time until recovery of radial Strain</measure>
    <time_frame>30 minutes</time_frame>
    <description>Time until recovery of radial Strain in the myocardial segments subtended by the target vessel (defined more than 80 percent recovery compared to 30 minutes post balloon occlusion)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent Akinesia</measure>
    <time_frame>1, 10, 30, 60, 120, 180 and 300 minutes and 24, 48 and 72 hours</time_frame>
    <description>Percent Akinesia in the myocardial segments</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radial myocardial Strain</measure>
    <time_frame>1, 10, 30, 60, 120, 180 and 300 minutes and 24, 48 and 72 hours</time_frame>
    <description>Radial myocardial Strain (in percent) in the myocardial segments subtended by the target vessel measured with speckle tracking.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global longitudinal Strain</measure>
    <time_frame>1, 10, 30, 60, 120, 180 and 300 minutes and 24, 48 and 72 hours</time_frame>
    <description>Global longitudinal Strain (in percent) in the heart measured with speckle tracking.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial wall motion index</measure>
    <time_frame>1, 10, 30, 60, 120, 180 and 300 minutes and 24, 48 and 72 hours</time_frame>
    <description>Myocardial wall motion index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Left ventricular ejection fraction</measure>
    <time_frame>1, 10, 30, 60, 120, 180 and 300 minutes and 24, 48 and 72 hours</time_frame>
    <description>Left ventricular ejection fraction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Left ventricular stroke volume index</measure>
    <time_frame>1, 10, 30, 60, 120, 180 and 300 minutes and 24, 48 and 72 hours</time_frame>
    <description>Left ventricular stroke volume index</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Patients with a significant coronary artery lesion</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Balloon inflation for 90s</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Intracoronary balloon inflation</intervention_name>
    <description>Patients with a significant coronary artery lesion in a proximal coronary segment will undergo intracoronary balloon inflation for 90s prior to PCI.</description>
    <arm_group_label>Patients with a significant coronary artery lesion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age &gt;18 years.&#xD;
&#xD;
          2. Stable CAD with indication for PCI of a lesion in either of the following coronary&#xD;
             segments:&#xD;
&#xD;
               1. 6 or 7 (proximal or mid left anterior descending coronary artery)&#xD;
&#xD;
               2. 11 (Proximal left circumflex coronary artery)&#xD;
&#xD;
               3. 1 or 2 (proximal right coronary artery)&#xD;
&#xD;
          3. Normal cardiac function in the myocardial segments subtended by the target vessel, as&#xD;
             assessed by echocardiography at the time of coronary angiography.&#xD;
&#xD;
          4. Written informed consent obtained.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Pre-existing heart failure&#xD;
&#xD;
          2. Known pre-existing irreversible regional or global wall motion abnormalities affecting&#xD;
             the myocardial segments subtended by the target vessel.&#xD;
&#xD;
          3. Severe valvulopathy&#xD;
&#xD;
          4. Thrombolysis In Myocardial Infarction (TIMI) flow &lt;3 in the target vessel.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Björn Redfors</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sahlgrenska Universitetssjukhus</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Björn Redfors, AssocProf</last_name>
    <phone>+46 31 342 7543</phone>
    <email>Bjoern.Redfors@wlab.gu.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kardiologen</name>
      <address>
        <city>Gothenburg</city>
        <zip>41345</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Björn S Redfors, PhD, MD</last_name>
      <phone>+46313427543</phone>
      <email>Bjoern.Redfors@wlab.gu.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>July 5, 2021</study_first_submitted>
  <study_first_submitted_qc>August 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 26, 2021</study_first_posted>
  <last_update_submitted>October 11, 2021</last_update_submitted>
  <last_update_submitted_qc>October 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Percutaneous Coronary Intervention</keyword>
  <keyword>Myocardial stunning</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Due to GDPR regulation</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

